A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results for " Cefazolin "

Picture of Cefazolin EP Impurity D

Cefazolin EP Impurity D

SZ CAT No:SZ-C016005
CAS No32510-61-5
Mol.F.C13H14N6O6S
Mol.Wt.382.4
Inv. StatusLimited Stock
Rel. CAS No27164-45-0 (Na salt) ; 117030-04-3 (K salt)

Chemical Name: (6R,7R)-3-[(Acetyloxy)methyl]-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (as per EP); (6R,7R)-7-[2-(1H-Tetrazol-1-yl)acetamido]-3-(acetoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (as per USP)

Synonym: Cefazolin Acetoxy Analog (USP)

Shipping Temperature: Ambient

HSN Code: 38229010

Country of Origin: India

Smiles: O=C(C(N12)=C(COC(C)=O)CS[C@]2([H])[C@H](NC(CN3N=NN=C3)=O)C1=O)O

Cefazolin EP Impurity D is chemically (6R,7R)-3-[(Acetyloxy)methyl]-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (as per EP); (6R,7R)-7-[2-(1H-Tetrazol-1-yl)acetamido]-3-(acetoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (as per USP) . It is also known as Cefazolin Acetoxy Analog (USP). Cefazolin EP Impurity D is supplied with detailed characterization data compliant with regulatory guideline. Cefazolin EP Impurity D can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cefazolin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.